RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Zhang to Anticholesteremic Agents

Back to Details
This is a "connection" page, showing publications John Zhang has written about Anticholesteremic Agents.
John Zhang
Connection Strength
0.632
Anticholesteremic Agents
  1. Yu J, Li X, Matei N, McBride D, Tang J, Yan M, Zhang JH. Ezetimibe, a NPC1L1 inhibitor, attenuates neuronal apoptosis through AMPK dependent autophagy activation after MCAO in rats. Exp Neurol. 2018 09; 307:12-23.
    View in: PubMed
    Score: 0.632
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support